We don’t usually report on labor and employment cases in this space.
Heck, we don’t usually read labor and employment cases.
But the recent decision in Mylan Pharmaceuticals , Inc. v. United Steel, Paper and Forestry, Local 8-957, No. 1:07CV4, 2008 U.S. Dist. LEXIS 17988 (N.D.W. Va. Mar. 6, 2008), compels us to speak.
We typically post about product liability (and mass tort) issues affecting pharmaceutical and medical device companies. But we’re taking a short detour today simply to note that pharmaceutical companies are now facing another litigation threat: overtime wage cases.
Since September 2006, a consortium of law firms that includes Kingsley & Kingsley, APC; Spiro Moss Barness